Skip to content

Effects of physical exercise associated with laser therapy on functional capacity and muscle performance in individuals with persistent symptoms of Covid-19

Effects of physical exercise associated with photobiomodulation therapy on functional capacity and muscle performance in individuals with persistent symptoms of Covid-19

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-67wbv3r
Enrollment
Unknown
Registered
2022-07-06
Start date
2022-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Pain

Interventions

A sample of 32 participants should be included in the study, which will be randomized in blocks to define the order of application of treatments, and may be allocated to two groups, Photobiomodulation
in the first week the individuals will be evaluated before the 1st session and will receive 3 sessions of photobiomodulation or placebo, being reevaluated after the 3rd session. In the second week the
E02.594.540

Sponsors

Universidade Federal de Santa Catarina - Campus Araranguá
Lead Sponsor
Laboratório de Avaliação e Reabilitação do Aparelho Locomotor-LARAL (UFSC/Campus Araranguá)
Collaborator

Eligibility

Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Individuals aged between 18 and 70 years, of both genders with musculoskeletal pain, myalgia or arthralgia, persisting after four weeks of Covid-19 infection. Individuals with pain rating equal to or greater than 3 on the Visual Analogue Scale. Individuals classified as grade 1, 2 and 3 on the modified Medical Research Council scale

Exclusion criteria

Exclusion criteria: Individuals with pain rating lower than 3 on the Visual Analogue Scale. Individuals with grades 4 and 5 on the modified Medical Research Council scale. Individuals with chronic pain complaint in the treatment region, prior to Covid-19. Individuals with epilepsy, fibromyalgia, cardiac alterations and decompensated diabetes. Recent surgeries in regions related to the treatment site with less than 3 months; Laser photosensitivity; Continuous use of analgesics, muscle relaxants or anti-inflammatory drugs in the 48 hours prior to the intervention. pregnant women. Individuals with neurological and cognitive dysfunctions, such as dementia, intellectual disability, communicative deficit or any other condition that makes it impossible to understand the study procedures

Design outcomes

Primary

MeasureTime frame
To evaluate the threshold of pain by pressure, using algometry as a method, with an analog algometer. Where we will measure pain intensity in kilogram-force before the first session, after the third session, and after four weeks of treatment. It is expected to find at least a 5% variation in pre- and post-intervention measurements between the intervention and placebo groups

Secondary

MeasureTime frame
To evaluate quality using the The World Health Organization Quality of Life Questionnaire as a method, where we will calculate scores for the physical, psychological, social relations, and environment domains before the first session, after the third session, and after four weeks of treatment. It is expected to find at least a 5% variation in pre- and post-intervention measurements between the intervention and placebo groups ;Assess pain using the Multidimensional Pain Rating Scale as a method. Where we will evaluate the intensity of pain, which varies between 0 and 10, the location of pain by means of a body diagram, and the pain descriptors for language evaluation. The assessment will be done before the first session, after the third session, and after four weeks of treatment. It is expected to find a variation of at least 5% in pre- and post-intervention measurements between the intervention and placebo groups;Evaluation of the physical and functional performance of patients, using the 5-repetition Sit and Stand Up Chair Test as a method. We will measure the time it takes the individual to get up five times from a sitting position, as quickly as possible, before the first session, after the third session, and after four weeks of treatment. We expect to find at least a 5% variation in pre- and post-intervention measurements between the intervention and placebo groups

Countries

Brazil

Contacts

Public ContactAnne Bilby

Universidade Federal de Santa Catarina. Campus Araranguá

annepang.fisioterapia@gmail.com+55-092-988053702

Outcome results

None listed

Source: REBEC (via WHO ICTRP)